CardioMEMS Shows Promise for Expanded Use Despite Falling Short in Trial
By Kate Buron When The U.S. Food and Drug Administration (FDA) approved the CardioMEMS HF System in 2014, Abbott harnessed the power of artificial intelligence (AI) coupled with telemedicine for managing patients with heart failure (HF). Expanded use of the system was the objective of a new trial initiated in 2018, but the onset of […]
Using Artificial Intelligence to Predict CV Risk Assessment
It is well-established that patients with the highest proportion of visceral fat area are more likely to experience a heart attack or other cardiovascular event. While abdominal CT scans can provide a more granular look at body composition when routinely performed, ascertaining risk levels based on fat area is rarely done in clinical practice. Manually […]
